Effects of aldose reductase inhibitor in diabetic rats

被引：0

作者：

Nagai, T ^{[1
]}

Sekizuka, E ^{[1
]}

Tsukada, K ^{[1
]}

Shimizu, T ^{[1
]}

Minamitani, H ^{[1
]}

Hokari, R ^{[1
]}

Oshio, C ^{[1
]}

机构：

[1] Keio Univ, Fac Sci & Technol, Inst Biomed Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan

来源：

PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND | 1998年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In microcirculation, RBC deformability is one of the most important factor. In this study, the effect of aldose reductase inhibitor (ARI) on RBC deformability in diabetic rats was investigated. Seven-week-old Wistar male rats were used as a diabetic model. We injected streptozotocin (STZ) (55mg/kg) intraperitoneally to make them diabetic. And then we administered ARI orally to the STZ rats. We classified them into STZ injected diabetic group (DM) and STZ and ARI treated diabetic group (ARI). Experiments were performed three weeks after STZ treatment. The RBC deformability was measured directly from the microscope images of mesentery. From this experiment, it was found that ARI didn't alter HbA1c, but improved the decreased RBC deformability in diabetes to the normal level.

引用

页码：3098 / 3099

页数：2

共 50 条

[31] Effect of Ranirestat, a New Aldose Reductase Inhibitor, on Diabetic Retinopathy in SDT Rats
Toyoda, Fumihiko
Tanaka, Yoshiaki
Ota, Ayumi
Shimmura, Machiko
Kinoshita, Nozomi
Takano, Hiroko
Matsumoto, Takafumi
Tsuji, Junichi
Kakehashi, Akihiro
JOURNAL OF DIABETES RESEARCH, 2014, 2014
[32] ADMINISTRATION OF AN ALDOSE REDUCTASE INHIBITOR INDUCES A DECREASE OF COLLAGEN FLUORESCENCE IN DIABETIC RATS
SUAREZ, G
RAJARAM, R
BHUYAN, KC
ORONSKY, AL
GOIDL, JA
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (02): : 624 - 627
[33] THE EFFECT OF AN ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON THE LEVEL OF METABOLITES IN LENSES OF DIABETIC RATS
GONZALEZ, AM
SOCHOR, M
MCLEAN, P
DIABETES, 1983, 32 (05) : 482 - 485
[34] CRANIAL NERVE NEUROPATHY OF DIABETIC RATS IS PREVENTED BY TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
NOTVEST, RR
INSERRA, JJ
KEIM, KL
DIABETES, 1986, 35 : A206 - A206
[35] Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats
Hotta, N
Koh, N
Sakakibara, F
Nakamura, J
Hara, T
Hamada, Y
Fukasawa, H
Kakuta, H
Sakamoto, N
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (01) : 45 - 51
[36] TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR, PREVENTS NERVE DYSFUNCTION IN CONSCIOUS DIABETIC RATS
NOTVEST, RR
INSERRA, JJ
DIABETES, 1987, 36 (04) : 500 - 504
[37] Prevention of diabetic ocular complications in spontaneously diabetic Torii rats by aldose reductase inhibitor fidarestat
Kakehashi, A
Saito, Y
Ono, R
Sugi, N
Mori, K
Kuroki, M
Kawakami, M
Kanazawa, Y
Hirooka, H
Kato, N
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U92 - U92
[38] An aldose reductase inhibitor, fidarestat, prevents diabetic ocular complications in spontaneously diabetic Torii rats
Kakehashi, Akihiro
Takezawa, Mikiko
Toyoda, Fumihiko
Noshita, Nozomiki
Mameuda, Chiho
Yamagami, Hiroko
Kato, Noriaki Kato Noriaki
Ishikawa, San-E
Kawakami, Masanobu
Kanazawa, Yasunori
DIABETES, 2008, 57 : A233 - A233
[39] Effects of aldose reductase inhibitor on peripheral muscle sympathetic nerve activity in streptozotocin-induced diabetic rats
Kusunoki, M.
Shinzawa, G.
Nakamura, T.
DIABETOLOGIA, 2009, 52 : S440 - S441
[40] THE EFFECT OF A NEW ALDOSE REDUCTASE INHIBITOR ON THE DEVELOPMENT OF DIABETIC AND NAPHTHALENE CATARACTS IN BN RATS
WEGENER, A
HOCKWIN, O
PAPE, G
SCHNEIDER, R
OPHTHALMIC RESEARCH, 1985, 17 (04) : 190 - 191

← 1 2 3 4 5 →